MATRITECH INC/DE/
10-Q, EX-27.1, 2000-08-11
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: MATRITECH INC/DE/, 10-Q, EX-10.1, 2000-08-11
Next: FIRST FEDERAL BANCORP INC/OH/, 10QSB, 2000-08-11



<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                       6,067,990
<SECURITIES>                                         0
<RECEIVABLES>                                  259,736
<ALLOWANCES>                                         0
<INVENTORY>                                    396,176
<CURRENT-ASSETS>                             6,895,028
<PP&E>                                       2,175,636
<DEPRECIATION>                             (1,355,228)
<TOTAL-ASSETS>                               8,053,481
<CURRENT-LIABILITIES>                        1,142,281
<BONDS>                                              0
                                0
                                          0
<COMMON>                                       250,333
<OTHER-SE>                                   6,449,732
<TOTAL-LIABILITY-AND-EQUITY>                 8,053,481
<SALES>                                        329,691
<TOTAL-REVENUES>                               518,306
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                             3,080,089
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                            (2,561,783)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (2,561,783)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (2,561,783)
<EPS-BASIC>                                      (.10)
<EPS-DILUTED>                                    (.10)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission